442 related articles for article (PubMed ID: 14561388)
21. [Clinical use of hematopoietic growth factors].
Krusius T
Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
[No Abstract] [Full Text] [Related]
22. Clinical use of recombinant hematopoietic colony-stimulating factors.
Shepro DS; Sullivan R
Adv Intern Med; 1991; 36():329-62. PubMed ID: 2024585
[No Abstract] [Full Text] [Related]
23. Treatment strategies and issues in low/intermediate-1-risk myelodysplastic syndrome (MDS) patients.
Bowen DT
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S16-23. PubMed ID: 16085013
[TBL] [Abstract][Full Text] [Related]
24. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
Ganser A; Hoelzer D
Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
[No Abstract] [Full Text] [Related]
25. Predicting erythroid response to recombinant erythropoietin plus granulocyte colony-stimulating factor therapy following a single subcutaneous bolus in patients with myelodysplasia.
Bowen D; Hyslop A; Keenan N; Groves M; Culligan D; Johnson P; Shaw A; Geddes F; Evans P; Porter J; Cavill I
Haematologica; 2006 May; 91(5):709-10. PubMed ID: 16670077
[TBL] [Abstract][Full Text] [Related]
26. Treatment with growth factors in myelodysplastic syndromes.
Geissler RG; Schulte P; Ganser A
Pathol Biol (Paris); 1997 Oct; 45(8):656-67. PubMed ID: 9569932
[TBL] [Abstract][Full Text] [Related]
27. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
[TBL] [Abstract][Full Text] [Related]
28. Hematopoietic growth factors in the treatment of the myelodysplastic syndromes.
Ganser A
Curr Opin Hematol; 1995 May; 2(3):204-9. PubMed ID: 9371996
[TBL] [Abstract][Full Text] [Related]
29. [Myeloproliferative syndromes].
Ganser A
Ther Umsch; 1996 Feb; 53(2):97-102. PubMed ID: 8629270
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietic growth factors in autologous bone marrow transplantation.
Miller AM
Semin Oncol; 1993 Oct; 20(5 Suppl 6):88-95. PubMed ID: 7692607
[TBL] [Abstract][Full Text] [Related]
31. [Use of hematopoietic growth factors in oncology].
Delmer A; Zittoun R
Bull Cancer; 1991; 78(2):115-31. PubMed ID: 2036483
[TBL] [Abstract][Full Text] [Related]
32. [The role of hematopoietic growth factors on extensive apoptosis of myelodysplastic hematopoietic cells and its clinical significance].
Cao Z; Li R; Li Q
Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):27-30. PubMed ID: 10921099
[TBL] [Abstract][Full Text] [Related]
33. Cytokine targets in the treatment of myelodysplastic syndromes.
Verma A; List AF
Curr Hematol Rep; 2005 Nov; 4(6):429-35. PubMed ID: 16232378
[TBL] [Abstract][Full Text] [Related]
34. Response to recombinant erythropoietin alpha, without the adjunct of granulocyte-colony stimulating factor, is associated with a longer survival in patients with transfusion-dependent myelodysplastic syndromes.
Musto P; Villani O; Martorelli MC; Pietrantuono G; Guariglia R; Mansueto G; D'Auria F; Grieco V; Bianchino G; Sparano A; Zonno A; Lerose R; Sanpaolo G; Falcone A
Leuk Res; 2010 Aug; 34(8):981-5. PubMed ID: 19931907
[TBL] [Abstract][Full Text] [Related]
35. Update on the therapy for myelodysplastic syndrome.
Kasner MT; Luger SM
Am J Hematol; 2009 Mar; 84(3):177-86. PubMed ID: 19195035
[TBL] [Abstract][Full Text] [Related]
36. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
37. Use of granulocyte colony-stimulating factor for treatment of aplastic anemia.
Kojima S
Nagoya J Med Sci; 1999 Nov; 62(3-4):77-82. PubMed ID: 10689869
[TBL] [Abstract][Full Text] [Related]
38. Clinical use of hematopoietic growth factors.
Löwenberg B; Dale DC; Sheridan WP
Rev Invest Clin; 1994 Apr; Suppl():33-40. PubMed ID: 7886306
[No Abstract] [Full Text] [Related]
39. The Myelodysplastic Syndromes.
Cheson BD
Oncologist; 1997; 2(1):28-39. PubMed ID: 10388027
[TBL] [Abstract][Full Text] [Related]
40. Supportive care, growth factors, and new therapies in myelodysplastic syndromes.
Hellström-Lindberg E; Malcovati L
Blood Rev; 2008 Mar; 22(2):75-91. PubMed ID: 18068281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]